The University of Southampton
University of Southampton Institutional Repository

Immunotherapy for hepatocellular carcinoma: Current and future

Immunotherapy for hepatocellular carcinoma: Current and future
Immunotherapy for hepatocellular carcinoma: Current and future

Hepatocellular carcinoma (HCC) arises on the background of chronic liver disease. Despite the development of effective anti-viral therapeutics HCC is continuing to rise, in part driven by the epidemic of non-alcoholic fatty liver disease. Many patients present with advanced disease out with the criteria for transplant, resection or even locoregional therapy. Currently available therapeutics for HCC are effective in a small minority of individuals. However, there has been a major global interest in immunotherapies for cancer and although HCC has lagged behind other cancers, great opportunities now exist for treating HCC with newer and more sophisticated agents. Whilst checkpoint inhibitors are at the forefront of this revolution, other therapeutics such as inhibitory cytokine blockade, oncolytic viruses, adoptive cellular therapies and vaccines are emerging. Broadly these may be categorized as either boosting existing immune response or stimulating de novo immune response. Although some of these agents have shown promising results as monotherapy in early phase trials it may well be that their future role will be as combination therapy, either in combination with one another or in combination with treatment modalities such as locoregional therapy. Together these agents are likely to generate new and exciting opportunities for treating HCC, which are summarized in this review.

Adoptive cell therapy, Cancer vaccine, Checkpoint inhibitor, Hepatocellular carcinoma, Immunotherapy, Liver cancer, Oncolytic virus
1007-9327
2977-2989
Johnston, Michael P.
50f7f267-8e9e-497c-84dd-15f905b9419d
Khakoo, Salim I.
6c16d2f5-ae80-4d9b-9100-6bfb34ad0273
Johnston, Michael P.
50f7f267-8e9e-497c-84dd-15f905b9419d
Khakoo, Salim I.
6c16d2f5-ae80-4d9b-9100-6bfb34ad0273

Johnston, Michael P. and Khakoo, Salim I. (2019) Immunotherapy for hepatocellular carcinoma: Current and future. World Journal of Gastroenterology, 25 (24), 2977-2989. (doi:10.3748/wjg.v25.i24.2977).

Record type: Review

Abstract

Hepatocellular carcinoma (HCC) arises on the background of chronic liver disease. Despite the development of effective anti-viral therapeutics HCC is continuing to rise, in part driven by the epidemic of non-alcoholic fatty liver disease. Many patients present with advanced disease out with the criteria for transplant, resection or even locoregional therapy. Currently available therapeutics for HCC are effective in a small minority of individuals. However, there has been a major global interest in immunotherapies for cancer and although HCC has lagged behind other cancers, great opportunities now exist for treating HCC with newer and more sophisticated agents. Whilst checkpoint inhibitors are at the forefront of this revolution, other therapeutics such as inhibitory cytokine blockade, oncolytic viruses, adoptive cellular therapies and vaccines are emerging. Broadly these may be categorized as either boosting existing immune response or stimulating de novo immune response. Although some of these agents have shown promising results as monotherapy in early phase trials it may well be that their future role will be as combination therapy, either in combination with one another or in combination with treatment modalities such as locoregional therapy. Together these agents are likely to generate new and exciting opportunities for treating HCC, which are summarized in this review.

Text
WJG-25-2977 - Version of Record
Download (1MB)

More information

Accepted/In Press date: 18 May 2019
e-pub ahead of print date: 28 June 2019
Keywords: Adoptive cell therapy, Cancer vaccine, Checkpoint inhibitor, Hepatocellular carcinoma, Immunotherapy, Liver cancer, Oncolytic virus

Identifiers

Local EPrints ID: 432853
URI: https://eprints.soton.ac.uk/id/eprint/432853
ISSN: 1007-9327
PURE UUID: 7b1eac11-6c95-40bd-a42f-f4f19fb615b8

Catalogue record

Date deposited: 31 Jul 2019 16:30
Last modified: 19 Nov 2019 17:31

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×